Mediwound Ltd
NASDAQ:MDWD
Mediwound Ltd
NASDAQ:MDWD
Price:
16.58
USD
Market Closed
Market Cap:
$212.9m
Balance Sheet
Balance Sheet Decomposition
Mediwound Ltd
Mediwound Ltd
Balance Sheet Decomposition is not available for
Mediwound Ltd
Mediwound Ltd
Balance Sheet
Mediwound Ltd
Mediwound Ltd
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
3
|
0
|
2
|
25
|
43
|
29
|
36
|
7
|
7
|
17
|
11
|
34
|
42
|
9
|
5
|
|
| Cash |
3
|
0
|
2
|
25
|
43
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
36
|
7
|
7
|
17
|
11
|
34
|
42
|
9
|
5
|
|
| Short-Term Investments |
1
|
0
|
8
|
39
|
3
|
1
|
0
|
17
|
22
|
4
|
0
|
0
|
30
|
34
|
48
|
|
| Total Receivables |
0
|
2
|
2
|
2
|
3
|
3
|
3
|
7
|
5
|
3
|
2
|
10
|
4
|
6
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
2
|
9
|
4
|
5
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
2
|
2
|
3
|
7
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Inventory |
0
|
1
|
0
|
1
|
2
|
1
|
2
|
2
|
2
|
1
|
1
|
2
|
3
|
3
|
4
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
5
|
3
|
12
|
69
|
50
|
34
|
42
|
33
|
36
|
26
|
15
|
46
|
50
|
52
|
60
|
|
| PP&E Net |
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
4
|
4
|
16
|
21
|
26
|
|
| PP&E Gross |
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
5
|
5
|
4
|
4
|
16
|
21
|
26
|
|
| Accumulated Depreciation |
3
|
4
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
6
|
7
|
8
|
8
|
8
|
9
|
|
| Intangible Assets |
5
|
5
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Assets |
12
N/A
|
25
+110%
|
15
-42%
|
71
+380%
|
53
-26%
|
36
-32%
|
44
+23%
|
35
-20%
|
41
+15%
|
31
-23%
|
20
-36%
|
50
+153%
|
66
+33%
|
73
+11%
|
86
+17%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
4
|
3
|
5
|
6
|
6
|
5
|
8
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
4
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
|
| Short-Term Debt |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
3
|
4
|
3
|
3
|
18
|
14
|
|
| Total Current Liabilities |
2
|
3
|
2
|
4
|
5
|
5
|
5
|
5
|
10
|
8
|
11
|
12
|
11
|
27
|
26
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
6
|
7
|
8
|
|
| Other Liabilities |
6
|
6
|
33
|
24
|
24
|
23
|
29
|
21
|
13
|
14
|
12
|
26
|
18
|
9
|
9
|
|
| Total Liabilities |
8
N/A
|
10
+26%
|
35
+253%
|
28
-18%
|
29
+3%
|
28
-4%
|
35
+23%
|
26
-24%
|
25
-3%
|
24
-6%
|
24
+2%
|
39
+61%
|
35
-11%
|
42
+21%
|
43
+1%
|
|
| Equity | ||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
43
|
32
|
47
|
66
|
88
|
107
|
129
|
131
|
126
|
135
|
149
|
168
|
175
|
205
|
229
|
|
| Additional Paid In Capital |
47
|
48
|
62
|
109
|
112
|
115
|
139
|
140
|
141
|
142
|
144
|
179
|
206
|
236
|
272
|
|
| Treasury Stock |
0
|
0
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
16
+261%
|
20
N/A
|
43
N/A
|
23
-45%
|
8
-67%
|
10
+24%
|
9
-7%
|
15
+69%
|
7
-52%
|
5
N/A
|
11
N/A
|
32
+190%
|
31
-1%
|
44
+40%
|
|
| Total Liabilities & Equity |
12
N/A
|
25
+110%
|
15
-42%
|
71
+380%
|
53
-26%
|
36
-32%
|
44
+23%
|
35
-20%
|
41
+15%
|
31
-23%
|
20
-36%
|
50
+153%
|
66
+33%
|
73
+11%
|
86
+17%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
7
|
9
|
11
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
